Therapeutic efficacy observation of Tuina manipulation for pediatric adenoid hypertrophy
- VernacularTitle:推拿手法治疗小儿腺样体肥大的临床疗效观察
- Author:
Kun-Peng LIU
;
Jia-Wen CUI
;
Fei GU
;
Min FANG
;
Yi-Chao WANG
;
Shu-Xia WANG
;
Cheng WANG
;
Jun-Liang WANG
;
Chao ZHOU
;
Deng-Jun JI
;
Ya-Zhou LI
;
Li-Jun HU
- Keywords:
Tuina;
Massage;
Pediatric Tuina;
Adenoid Hypertrophy;
Pharyngeal Tonsil
- From:
Journal of Acupuncture and Tuina Science
2021;19(6):425-431
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To observe the clinical efficacy of Tuina (Chinese therapeutic massage) manipulation for pediatric adenoid hypertrophy (AH). Methods: A total of 60 children with AH were randomized into an observation group and a medication group, with 30 cases in each group. The observation group was treated with pediatric Tuina treatment, and the medication group was treated with 0.05％ mometasone furoate nasal spray. The changes of main clinical symptom score, quality of life (QOL) score and X-ray nasopharynx lateral film were observed, and the clinical efficacy was evaluated. Results: The total effective rate of the observation group was 90.0％, and that of the medication group was 66.7％. The difference between the two groups was statistically significant (P<0.05). After treatment, the A/N value [ratio of adenoid thickness (A) and nasopharyngeal cavity width (N)] of posterior nasopharyngeal lateral film did not show significant change in either group (P>0.05). After treatment, the clinical symptom scores in both groups decreased, and the intra-group differences were statistically significant (P<0.001), but there was no statistical difference between the two groups (P>0.05). After treatment, the QOL scores of children in both groups decreased, and the intra-group differences were statistically significant (P<0.001), and the difference between the two groups was statistically significant (P<0.001). Conclusion: Tuina manipulation is effective in treating pediatric AH, and produces a better effect in improving traditional Chinese medicine symptoms and QOL than 0.05％ mometasone furoate nasal spray.
